Mobia Medical To Participate In The Piper Sandler 38Th Annual Healthcare Conference


Date:

(MENAFN- GlobeNewsWire - Nasdaq) AUSTIN, Texas, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that members of management will present and host one-on-one investor meetings at the upcoming Piper Sandler 38th Annual Healthcare Conference in New York. The presentation will take place on Tuesday, December 1, 2026, at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

Event: Piper Sandler 38 th Annual Healthcare Conference
Date: Tuesday, December 1, 2026
Time: 5:30 a.m. PT / 8:30 a.m. ET
Webcast:

A live and archived version of the presentation will be available via the News & Events page of the investor section of Mobia Medical's website.

About Mobia Medical, Inc.

Mobia Medical, Inc. is a medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company's Vivistim® Paired VNSTM System is the first and only clinically validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNSTM System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.

Investor Relations Contact

Louisa Smith
Gilmartin Group, LLC
...

Media Inquiries Contact

Terri Clevenger
...


MENAFN17112026004107003653ID1111978939


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search